Coffee review

Us studies show that smoking and drinking coffee help reduce the risk of Parkinson's disease

Published: 2024-09-19 Author: World Gafei
Last Updated: 2024/09/19, Researchers at Duke University Medical Center in the United States say people with Parkinson's disease drink less coffee and smoke less than other family members who are not sick, the Daily Health News reported. Their findings were published in April in the Archives of Neurology. Previous studies have shown that drinking coffee, smoking and taking non-steroidal anti-inflammatory drugs (NSAIDS) such as aspirin and cloth

Researchers at Duke University Medical Center in the United States say people with Parkinson's disease drink less coffee and smoke less than other family members who are not sick, the Daily Health News reported. Their findings were published in April in the Archives of Neurology.

Previous studies have shown that drinking coffee, smoking and taking non-steroidal anti-inflammatory drugs (NSAIDS) such as aspirin, ibuprofen and naproxen can help prevent Parkinson's disease, but few family studies have explored this correlation.

The new study included 356 patients with Parkinson's disease (with an average age of about 66) and 317 family members (with an average age of about 64). The results showed that patients with Parkinson's disease had 44% fewer smokers than unaffected family members, and the proportion of current smokers was 70% less; increased coffee consumption and intensity were negatively correlated with Parkinson's disease; taking NSAID was not associated with Parkinson's disease.

The researchers say it is not clear why smoking and drinking coffee help reduce the risk of Parkinson's disease. Because Parkinson's disease is complex, these environmental factors do not play a role in isolation, so the important role of gene-environment interaction in Parkinson's disease susceptibility should be emphasized. Smoking and caffeine may regulate the familial genetic effects of Parkinson's disease and should be included as an effect modifier in Parkinson's syndrome gene research.

0